Want to enter the
Asian healthcare market?Let us open the door for you.
A rapidly aging society.
A growing demand for healthcare.
We help you navigate the documentary and
regulatory complexities of Japan.
A doorstep to the vast Chinese market.
We solidified our presence here in 2011
through a strategic acquisition.
Emerging as a top leader of clinical trials in Asia.
A CRO providing support for clinical trials and
application approval since 2007.
A very friendly tax and regulatory environment.
We’ve had outstanding success with
clinical trials here since 2006.
A country with a phenomenal growth rate.
Our expert multilingual staff has over
10 years experience here.
Tap into a huge ASEAN country.
Since 2004 we have been leveraging
this deep clinical resource pool.
Offers efficient entry into the massive
Chinese market. With a base in Hong Kong
since 2008, we are situated to benefit
from evolving legislation.
Home to 16% of the world's population,
20% of its disease. A growing biotech
market presents tremendous opportunity
for clinical trials.
Multi-ethnic population and competitive
costs. Malaysia has an established healthcare
infrastructure that provides a solid foundation
for clinical research.
A robust pharmaceutical and biotech center
for Asia. The country's high standards have
made Singapore an ideal headquarters for
EPSI's global arm since 2000.
Share this page